Who owns ELIEM THERAPEUTICS INC?
- Ticker: CLYM
- CUSIP Number: 28658r106
Tip: Access positions for across all investors
Analyze quarterly positions in Eliem Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Eliem Therapeutics stock
Who bought or sold ELIEM THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 11M | $45M | -64% | Dec 2025 |
|
| MPM Oncology Impact Management | 2.7M | $11M | 100% | Dec 2025 |
|
| ADAR1 Capital Management | 1.4M | $5.7M | 973% | Dec 2025 |
|
| Vanguard Group | 1.3M | $5.4M | 2% | Dec 2025 |
|
| Affinity Asset Advisors | 1.3M | $5.2M | 0% | Dec 2025 |
|
| Kynam Capital Management | 1.0M | $4.1M | 0% | Dec 2025 |
|
| Dr. Jeffrey R. Jay, M.D. | 980k | $3.9M | 100% | Dec 2025 |
|
| Sphera Funds Management | 932k | $3.7M | 114% | Dec 2025 |
|
| Point72 Asset Management | 717k | $2.9M | 100% | Dec 2025 |
|
| Driehaus Capital Management | 601k | $2.4M | 100% | Dec 2025 |
|
| Two Sigma Investments | 567k | $2.3M | 403% | Dec 2025 |
|
| Peapod Lane Capital | 566k | $2.3M | 1% | Dec 2025 |
|
| Nan Fung Trinity | 464k | $1.9M | 0% | Dec 2025 |
|
| Susquehanna International | 445k | $1.8M | 213% | Dec 2025 |
|
| BlackRock | 389k | $1.6M | -47% | Dec 2025 |
|
| Renaissance Technologies | 321k | $1.3M | -40% | Dec 2025 |
|
| Geode Capital Management | 311k | $1.2M | 0% | Dec 2025 |
|
| Marshall Wace | 304k | $1.2M | 32% | Dec 2025 |
|
| Millennium Management | 296k | $1.2M | -37% | Dec 2025 |
|
| TD Asset Management | 246k | $985k | 175% | Dec 2025 |
|
| Citadel Advisors | 239k | $956k | 100% | Dec 2025 |
|
| Goldman Sachs Group | 225k | $900k | 205% | Dec 2025 |
|
| 683 Capital Management | 202k | $807k | 100% | Dec 2025 |
|
| Jane Street | 187k | $750k | 135% | Dec 2025 |
|
| Bridgeway Capital Management | 159k | $637k | 46% | Dec 2025 |
|
| Manufacturers Life Insurance Company | 141k | $567k | 261% | Dec 2025 |
|
| Ameriprise Financial | 140k | $558k | 100% | Dec 2025 |
|
| State Street Corporation | 129k | $516k | 25% | Dec 2025 |
|
| Two Sigma Advisers | 125k | $499k | 54% | Dec 2025 |
|
| Northern Trust | 125k | $499k | -1% | Dec 2025 |
|
| Botty Investors | 121k | $486k | 100% | Dec 2025 |
|
| OMERS Administration Corporation | 86k | $342k | 100% | Dec 2025 |
|
| Seven Fleet Capital Management | 76k | $306k | 100% | Dec 2025 |
|
| UBS Group | 71k | $285k | -82% | Dec 2025 |
|
| LPL Financial | 62k | $248k | 2% | Dec 2025 |
|
| Barclays | 62k | $247k | 150% | Dec 2025 |
|
| Hudson Bay Capital Management | 49k | $195k | 100% | Dec 2025 |
|
| XTX Topco | 35k | $139k | 19% | Dec 2025 |
|
| Qube Research & Technologies | 35k | $138k | -5% | Dec 2025 |
|
| Citizens Financial Group | 28k | $113k | -39% | Dec 2025 |
|
| Hsbc Holdings | 25k | $99k | 107% | Dec 2025 |
|
| Springbok Capital Management | 20k | $80k | -51% | Dec 2025 |
|
| Balyasny Asset Management | 14k | $57k | 100% | Dec 2025 |
|
| JustInvest | 11k | $45k | -24% | Dec 2025 |
|
| William Blair $ Company | 11k | $44k | 100% | Dec 2025 |
|
| Chicago Partners Investment | 11k | $55k | 6% | Dec 2025 |
|
| Virtu Financial | 11k | $43k | 100% | Dec 2025 |
|
| Scientech Research | 10k | $42k | 100% | Dec 2025 |
|
| Persistent Asset Partners | 9.2k | $37k | -67% | Dec 2025 |
|
| FMR | 6.3k | $25k | -11% | Dec 2025 |
|
| Tower Research Capital | 3.4k | $13k | -75% | Dec 2025 |
|
| Harbour Investments | 2.0k | $8.0k | 0% | Dec 2025 |
|
| Advisor Group Holdings | 600.00 | $2.4k | -97% | Dec 2025 |
|
| NISA Investment Advisors | 573.00 | $2.3k | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 513.00 | $2.1k | -72% | Dec 2025 |
|
| CWM | 29.00 | $0 | -73% | Dec 2025 |
|
| Deutsche Bank Aktiengesellschaft | 1.00 | $4.000000 | 0% | Dec 2025 |
|
Who sold out of Eliem Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tang Capital Management | Sep 2025 | 1.0M | $2.0M |
| Cantor Fitzgerald, L. P. | Sep 2025 | 547k | $1.1M |
| Deep Track Capital | Sep 2025 | 510k | $1.0M |
| Alyeska Investment Group | Sep 2025 | 485k | $976k |
| Shay Capital | Sep 2025 | 150k | $302k |
| Diadema Partners | Sep 2025 | 137k | $274k |
| Susquehanna Portfolio Strategies | Sep 2025 | 18k | $37k |
| Squarepoint Ops | Sep 2025 | 18k | $36k |
| Walleye Trading Advisors | Sep 2025 | 15k | $30k |
| China Universal Asset Management | Sep 2025 | 12k | $24k |
| Federated Investors | Sep 2025 | 4.4k | $8.9k |
| Mirae Asset Global Investments | Sep 2025 | 2.6k | $5.3k |
| Gf Fund Management | Sep 2025 | 1.5k | $2.9k |
| EverSource Wealth Advisors | Sep 2025 | 224.00 | $449.993600 |
| SRS Capital Advisors | Sep 2025 | 53.00 | $106.000000 |
| Advisory Services Network | Sep 2025 | 32.00 | $64.000000 |
| SBI Securities | Sep 2025 | 13.00 | $26.000000 |